A detailed history of Wellington Management Group LLP transactions in Ardelyx, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 107,345 shares of ARDX stock, worth $589,324. This represents 0.0% of its overall portfolio holdings.

Number of Shares
107,345
Previous 118,270 9.24%
Holding current value
$589,324
Previous $814,000 31.94%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

SELL
$4.49 - $6.85 $49,053 - $74,836
-10,925 Reduced 9.24%
107,345 $554,000
Q3 2024

Nov 14, 2024

SELL
$5.28 - $7.57 $17,577 - $25,200
-3,329 Reduced 2.74%
118,270 $814,000
Q2 2024

Aug 13, 2024

BUY
$5.89 - $9.31 $99,794 - $157,739
16,943 Added 16.19%
121,599 $901,000
Q1 2024

May 15, 2024

BUY
$6.05 - $9.74 $633,168 - $1.02 Million
104,656 New
104,656 $763,000
Q4 2023

Feb 12, 2024

BUY
$3.29 - $6.64 $351,802 - $710,021
106,931 New
106,931 $662,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $849M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.